Publications en collaboration avec des chercheurs de University College London (25)

2024

  1. CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease

    Alzheimer's and Dementia

2023

  1. Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology

    Alzheimer's and Dementia, Vol. 19, Núm. 3, pp. 807-820

  2. Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning

    Genome Medicine, Vol. 15, Núm. 1

  3. Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits

    Alzheimer's and Dementia, Vol. 19, Núm. 6, pp. 2317-2331

2022

  1. CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 11, pp. 1764-1777

  2. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

    Cortex, Vol. 150, pp. 12-28

  3. Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset

    Frontiers in Aging Neuroscience, Vol. 14

  4. Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation

    Molecular Psychiatry, Vol. 27, Núm. 4, pp. 1990-1999

2021

  1. Differential early subcortical involvement in genetic FTD within the GENFI cohort

    NeuroImage: Clinical, Vol. 30

  2. Replication study of plasma proteins relating to Alzheimer's pathology

    Alzheimer's and Dementia, Vol. 17, Núm. 9, pp. 1452-1464

  3. Sex-specific metabolic pathways were associated with alzheimer’s disease (Ad) endophenotypes in the european medical information framework for ad multimodal biomarker discovery cohort

    Biomedicines, Vol. 9, Núm. 11

  4. TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels

    Alzheimer's and Dementia, Vol. 17, Núm. 10, pp. 1628-1640

  5. The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort

    Alzheimer's Research and Therapy, Vol. 13, Núm. 1

2020

  1. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

    The Lancet Neurology, Vol. 19, Núm. 2, pp. 145-156

  2. Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia

    Brain Communications, Vol. 2, Núm. 2

  3. Cerebrospinal Fluid 7-Ketocholesterol Level is Associated with Amyloid-β42 and White Matter Microstructure in Cognitively Healthy Adults

    Journal of Alzheimer's disease : JAD, Vol. 76, Núm. 2, pp. 643-656

  4. Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

    Journal of Alzheimer's Disease, Vol. 77, Núm. 3, pp. 1353-1368

  5. Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

    Translational Psychiatry, Vol. 10, Núm. 1

  6. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 91, Núm. 3

  7. Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

    Cortex, Vol. 133, pp. 384-398